Amicus Therapeutics and Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing

NEXT STORY
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with Pfizer’s CDK4/6 Inhibitor Palbociclib
PREV STORY
Emerald Health Therapeutics Joint Venture Launches Cannabis-Free Endocannabinoid-Supporting Health Supplement in Canada
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp.

      -    Adds Two Rare Disease Medicines and Further Diversifies Company Revenue ...

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Announces First Quarter 2016 Financial Results

BURLINGAME, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage ...

author_avatar
NASDAQ Market News

Five Prime Therapeutics Receives FDA Orphan Drug Designation for FPA144 for the Treatment of Gastric Cancer

SOUTH SAN FRANCISCO, Calif., July 05, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

author_avatar
NASDAQ Market News